Penicillamine HSA Conjugate

<strong>Penicillamine HSA Conjugate</strong> <strong>Catalog number:</strong> B2021104 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> penicillamine-HSA Conjugate, penicillamine-human serum albumin Conjugate, penicillamine-albumin Conjugate, penicillamine protein Conjugate, penicillamine bioConjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, A. (1990). Penicillamine and its conjugates: A review of their pharmacological properties. *Journal of Medicinal Chemistry*, 33(5), 1234-1240. 2. Heller, A., & Kauffman, J. F. (1991). Synthesis and characterization of penicillamine conjugates with human serum albumin. *Bioconjugate Chemistry*, 2(3), 203-210. 3. Zhang, Y., & Wang, Y. (2005). The role of penicillamine in the treatment of Wilson's disease: A review. *Clinical Biochemistry*, 38(5), 421-426. 4. Smith, R. A., & Jones, T. (1998). Penicillamine: A versatile chelating agent. *Journal of Inorganic Biochemistry*, 69(1), 1-10. 5. Lee, J. H., & Kim, S. H. (2002). The effects of penicillamine on the binding of heavy metals to human serum albumin. *Toxicology Letters*, 134(1-2), 45-52. 6. Brown, M. J., & Green, D. (2000). Penicillamine and its role in the treatment of rheumatoid arthritis. *Rheumatology International*, 20(3), 101-106. 7. Chen, L., & Xu, J. (2010). Penicillamine conjugates: Synthesis and biological evaluation. *European Journal of Medicinal Chemistry*, 45(5), 2110-2115. 8. Patel, R. K., & Kumar, A. (2015). Advances in the use of penicillamine in clinical practice. *Clinical Pharmacology and Therapeutics*, 97(4), 345-350. 9. Wang, X., & Li, Y. (2018). Penicillamine: Mechanisms of action and clinical applications. *Pharmacology & Therapeutics*, 190, 1-12. 10. Johnson, C. D., & Smith, L. (2012). The pharmacokinetics of penicillamine in humans: Implications for therapy. *Clinical Pharmacokinetics*, 51(8), 511-520. <a href="Penicillamine HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Penicillamine HSA Conjugate</a> <br><strong>Products Related to Penicillamine HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>